Robert Langenbach

4.1k total citations · 1 hit paper
38 papers, 3.5k citations indexed

About

Robert Langenbach is a scholar working on Pharmacology, Molecular Biology and Genetics. According to data from OpenAlex, Robert Langenbach has authored 38 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 15 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Robert Langenbach's work include Inflammatory mediators and NSAID effects (22 papers), Estrogen and related hormone effects (9 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Robert Langenbach is often cited by papers focused on Inflammatory mediators and NSAID effects (22 papers), Estrogen and related hormone effects (9 papers) and Eicosanoids and Hypertension Pharmacology (5 papers). Robert Langenbach collaborates with scholars based in United States, Japan and Germany. Robert Langenbach's co-authors include Joseph Dinchuk, James M. Trzăskos, Hyunjung Jade Lim, Sudhansu K. Dey, Sanjoy Das, Bibhash C. Paria, Francesca Bosetti, Matthew D. Breyer, Scott G. Morham and Donald A. Young and has published in prestigious journals such as Cell, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Robert Langenbach

38 papers receiving 3.4k citations

Hit Papers

Multiple Female Reproductive Failures in Cyclooxygenase 2... 1997 2026 2006 2016 1997 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Langenbach United States 25 1.3k 946 791 753 517 38 3.5k
Joel F. Mahler United States 19 1.7k 1.3× 1.1k 1.1× 557 0.7× 1.9k 2.6× 537 1.0× 39 4.4k
Masato Katsuyama Japan 32 1.0k 0.8× 1.3k 1.3× 1.2k 1.5× 514 0.7× 412 0.8× 63 4.1k
Kimberly D. Kluckman United States 15 1.4k 1.1× 1.7k 1.8× 338 0.4× 771 1.0× 931 1.8× 17 4.5k
David F. Woodward United States 39 1.7k 1.4× 1.2k 1.3× 439 0.6× 317 0.4× 383 0.7× 149 4.9k
F. Nantel Canada 27 453 0.4× 1.2k 1.3× 350 0.4× 345 0.5× 168 0.3× 77 2.7k
Geoffrey J. Blackwell United Kingdom 16 1.2k 1.0× 1.2k 1.2× 468 0.6× 423 0.6× 618 1.2× 30 3.5k
Klaus van Leyen United States 37 404 0.3× 2.1k 2.2× 363 0.5× 146 0.2× 413 0.8× 74 4.3k
Rajan Singh United States 32 280 0.2× 1.3k 1.4× 265 0.3× 519 0.7× 319 0.6× 60 3.7k
Sei‐itsu Murota Japan 33 748 0.6× 1.4k 1.5× 290 0.4× 425 0.6× 418 0.8× 108 3.5k
Jean Sébastien Saulnier‐Blache France 39 824 0.7× 3.5k 3.7× 465 0.6× 172 0.2× 728 1.4× 98 5.9k

Countries citing papers authored by Robert Langenbach

Since Specialization
Citations

This map shows the geographic impact of Robert Langenbach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Langenbach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Langenbach more than expected).

Fields of papers citing papers by Robert Langenbach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Langenbach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Langenbach. The network helps show where Robert Langenbach may publish in the future.

Co-authorship network of co-authors of Robert Langenbach

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Langenbach. A scholar is included among the top collaborators of Robert Langenbach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Langenbach. Robert Langenbach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Iguchi, Genzo, Kali Chrysovergis, Seong‐Ho Lee, et al.. (2009). A reciprocal relationship exists between non-steroidal anti-inflammatory drug-activated gene-1 (NAG-1) and cyclooxygenase-2. Cancer Letters. 282(2). 152–158. 27 indexed citations
2.
3.
Aïd, Saba, Robert Langenbach, & Francesca Bosetti. (2008). Neuroinflammatory response to lipopolysaccharide is exacerbated in mice genetically deficient in cyclooxygenase-2. Journal of Neuroinflammation. 5(1). 17–17. 122 indexed citations
4.
Choi, Sangho, Robert Langenbach, & Francesca Bosetti. (2006). Cyclooxygenase‐1 and ‐2 enzymes differentially regulate the brain upstream NF‐κB pathway and downstream enzymes involved in prostaglandin biosynthesis. Journal of Neurochemistry. 98(3). 801–811. 51 indexed citations
5.
Basselin, Mireille, Nelly E. Villacreses, Robert Langenbach, et al.. (2006). Resting and arecoline‐stimulated brain metabolism and signaling involving arachidonic acid are altered in the cyclooxygenase‐2 knockout mouse. Journal of Neurochemistry. 96(3). 669–679. 25 indexed citations
6.
Steiner, Alexandre A., et al.. (2005). Expanding the febrigenic role of cyclooxygenase-2 to the previously overlooked responses. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 289(5). R1253–R1257. 36 indexed citations
7.
Schneider, André, Youfei Guan, Xiaoyan Zhang, et al.. (2004). Generation of a conditional allele of the mouse prostaglandin EP4 receptor. genesis. 40(1). 7–14. 75 indexed citations
9.
Wang, Tongguang, Liya Qin, Bin Liu, et al.. (2004). Role of reactive oxygen species in LPS‐induced production of prostaglandin E2in microglia. Journal of Neurochemistry. 88(4). 939–947. 206 indexed citations
10.
Carey, Michelle A., Dori R. Germolec, Robert Langenbach, & Darryl C. Zeldin. (2003). Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukotrienes and Essential Fatty Acids. 69(2-3). 157–162. 58 indexed citations
11.
Qi, Zhonghua, Chuan‐Ming Hao, Robert Langenbach, et al.. (2002). Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. Journal of Clinical Investigation. 110(1). 61–69. 13 indexed citations
12.
Qi, Zhonghua, Chuan‐Ming Hao, Robert Langenbach, et al.. (2002). Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. Journal of Clinical Investigation. 110(1). 61–69. 176 indexed citations
13.
Qi, Zhonghua, Chuan‐Ming Hao, Robert Langenbach, et al.. (2002). Opposite effects of cyclooxygenase-1 and -2 activity on the pressor response to angiotensin II. Journal of Clinical Investigation. 110(1). 61–69. 216 indexed citations
15.
Kömhoff, Martin, Junling Wang, Huifang Cheng, et al.. (2000). Cyclooxygenase-2–selective inhibitors impair glomerulogenesis and renal cortical development. Kidney International. 57(2). 414–422. 136 indexed citations
16.
Lim, Hyunjung Jade, Bibhash C. Paria, Sanjoy Das, et al.. (1997). Multiple Female Reproductive Failures in Cyclooxygenase 2–Deficient Mice. Cell. 91(2). 197–208. 1189 indexed citations breakdown →
17.
Detloff, Peter J., Simon W. M. John, W. Ronald Shehee, et al.. (1994). Deletion and Replacement of the Mouse Adult β-Globin Genes by a “Plug and Socket” Repeated Targeting Strategy. Molecular and Cellular Biology. 14(10). 6936–6943. 50 indexed citations
18.
Dieter, Michael P., et al.. (1990). The chemotherapeutic potential of glycol alkyl ethers: structure-activity studies of nine compounds in a Fischer-rat leukemia transplant model. Cancer Chemotherapy and Pharmacology. 26(3). 173–180. 14 indexed citations
19.
Langenbach, Robert, Eugene Elmore, & J. Carl Barrett. (1988). Tumor promoters : biological approaches for mechanistic studies and assay systems. Raven Press eBooks. 66 indexed citations
20.
Caspary, William J., Robert Langenbach, Bruce W. Penman, et al.. (1988). The mutagenic activity of selected compounds at the TK locus: Rodent vs. human cells. Mutation Research/Reviews in Genetic Toxicology. 196(1). 61–81. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026